The Anti-CDMO with CTMC's Jason Bock, Ph.D. and KSQ's Thomas Leitch
Business Of Biotech
Accelerating Cell Therapy Development: Challenges and Innovations
The chapter delves into the challenges faced in developing cell therapy, particularly in manufacturing, while emphasizing the potential of these therapies in curing cancer. It showcases the journey of creating an internal biotech within MD Anderson to accelerate cell therapy by industrializing research concepts and handling regulatory interactions. The discussion also highlights the transition of cell therapy from academic settings to industrialization, focusing on quality control, regulatory interactions, and innovative manufacturing techniques.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
